Prix Galien judges explain why it’s important to recognise innovation in the treatment of rare disease. Check out the video below.
Judges and past winners explain why UK Prix Galien is both a special and important occasion. Enjoy our montage below.
Dr. Dimitrios Georgiopoulos describes another Prix Galien win for Novartis – and why it’s so important. Check out Dimitrios’ story below.
Awards provide real world evidence that UK pharma remains at its innovative best London, 21st September, 2016. The first new treatment for heart failure in 15 years and Europe’s first approved stem cell therapy have scooped top prizes at the 2016 UK Prix Galien Awards. Novartis’ Entresto and Chiesi’s Holoclar won two of the three …
Shortlist provides real world evidence of UK pharma’s strength Treatments for lung cancer, ulcerative colitis, heart failure and idiopathic pulmonary fibrosis are among 16 innovations shortlisted for one of the most prestigious prizes in pharmaceutical R&D – a Prix Galien medal. The 2016 UK Prix Galien, which takes place at the House of Commons on …